Skip to Main Content

The rats had undergone surgery, and they were about to traverse some paper in the name of science.

Tim LaBranche and his colleagues at the drug maker Pfizer had operated on a group of lab rodents to replicate the effects of osteoarthritic joint damage. They had also given some of them a new pain drug, called an NGF inhibitor, while others got a placebo.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!